Goldline Pharmaceutical share price locked in 5% lower circuit after bumper debut

Goldline Pharmaceutical shares debuted strongly on BSE SME, opening at ₹59.75, 40% above the issue price of ₹43. The IPO, which closes on May 14, saw a subscription status of 600.53x by day 3.